Ferring Pharmaceuticals announced today that it has successfully completed the pivotal phase III study for degarelix, its novel prostate cancer treatment…
For the first time a once daily dosing regime of mesalazine (Pentasa® granules) has proven to be statistically superior to…
Ferring Pharmaceuticals today announced that it had come to an agreement with Cosmo Pharmaceuticals SpA for…
Ferring Pharmaceuticals today announced changes to the company’s Board of Directors. Effective immediately, Alexandra, Countess of Frederiksborg will become a new non-executive member of the Board…
New data presented today at the European Society of Human Reproduction and Embryology (ESHRE) 2007 congress shows that…
Medical, political and demographical experts drawn from across the globe have come together this week to discuss the ongoing challenges associated with access to infertility…
This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.
OKCette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.
OKIk bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals
OKEz az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.
OKTa strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.
OKЭта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.
OK